During the practical work for my diploma thesis — which
I completed in a pharmaceutical company's research laboratory focused on genetic engineering — I had the opportunity to see what a future work place could look like.
Not exact matches
Since its formation
in 2013, the Technology Gateway Network has
completed more than 2,750 projects with more than 1,250 Irish - based
companies on projects ranging from polymers to
pharmaceuticals, photonics to mobile services and mechatronics, right through to biotechnology and industrial design.
Research Triangle Park, NC — August 18, 2015 — Phoundry
Pharmaceuticals, Inc., an RTP, North Carolina — based
company focusing on the discovery of peptide therapeutics, announced today that it has successfully
completed its first seed financing, putting it
in position to advance its discovery and partnering plans.
It is hard to believe, for example, that Canada could not
in the end find common ground with the US on some extension of patent protection for
pharmaceuticals, since it was able to do so
in the just -
completed negotiations with the EU, or that an extension of the term of copyright protection from 50 to 70 years from the agreed baseline would have much if any real practical impact on Canada although it would be seen as a gain by the US given the heavy copyright portfolios of US entertainment
companies, allowing them an additional period of time to exploit their copyrighted content.
In March, researchers, in collaboration with the pharmaceutical company Ultragenyx, completed the first part of a Phase III clinical trial in adults with XLH — the final test of a drug before federal approva
In March, researchers,
in collaboration with the pharmaceutical company Ultragenyx, completed the first part of a Phase III clinical trial in adults with XLH — the final test of a drug before federal approva
in collaboration with the
pharmaceutical company Ultragenyx,
completed the first part of a Phase III clinical trial
in adults with XLH — the final test of a drug before federal approva
in adults with XLH — the final test of a drug before federal approval.
Mr. Damon's commitment to raise $ 1 million through that group and the OneXOne Foundation
in the next year was one of a bundle of pledges aimed at water and sanitation from individuals, charities and
companies totalling about $ 400 million (including a $ 200 million pledge by Napo
Pharmaceuticals to «
complete the clinical development of crofelemer, a drug that has potential to treat pediatric diarrhea, and provide it at cost to partner organizations for distribution
in the areas with the highest mortality and morbidity associated with diarrheal diseases.»)
The next twelve years of his career he spent
in in - house positions of increasing responsibility, at
companies to include Merck & Co., Inc., Genetics Institute, Inc. and Wyeth
Pharmaceuticals, Inc.Werten
completed his
in - house career with Celera Genomics (NYSE: CRA), the biotechnology
company located
in Rockville, Maryland and credited with sequencing the human genome.
«Provides analysis, commentary, and resources to help foreign
pharmaceutical and medical device
companies make sense of the ever - evolving FDA regulations and understand the
complete range of U.S. legal issues that may complicate bringing a drug, medical device, or other FDA - regulated product or service to market
in the United States.»
Even after
completing an associate degree, graduates will have to stay current with changes occurring
in the industry or with particular
pharmaceutical companies, since new drugs and generic brands are always entering the market.